- ►diabetesjournals.org T Danne, K Lüpke, K Walte, W von Schuetz, … - Diabetes Care, 2003 - Am Diabetes Assoc RESULTS—The mean pharmacokinetic profile of insulin detemir was similar across
all three age-groups. This was determined by statistical analyses of the data,
which showed no overall age effect or between-group differences when ... Cited by 89 - Related articles - BL Direct - All 11 versions
- ►viamedica.pl [PDF] - Free from Publisher P Vague, JL Selam, S Skeie, I De Leeuw, JWF … - Diabetes Care, 2003 - Am Diabetes Assoc 1 Hôpital de la Timone, Service Nutrition Endocrinologie et Maladies
Metabolique, Marseilles, France 2 Hotel Dieu, Service de Diabétologie, Paris,
France 3 Hjertelaget Research Foundation, Stavanger, Norway 4 Department of ... Cited by 232 - Related articles - BL Direct - All 8 versions
- ►novonordisk.co.uk [PDF] T Heise, L Nosek, BB Rønn, L Endahl, L … - Diabetes, 2004 - Am Diabetes Assoc The aim of this randomized double-blind study was to compare the within-subject
variability of the glucose-lowering effect of a novel insulin analog, insulin
detemir, with that of insulin glargine and NPH insulin in people with type ... Cited by 293 - Related articles - BL Direct - All 13 versions
- ►diabetesjournals.org K Hermansen, S Madsbad, H Perrild, A … - Diabetes Care, 2001 - Am Diabetes Assoc OBJECTIVE— Insulin detemir (NN304) is a soluble basal insulin analog developed
to cover basal insulin requirements. This trial aimed to compare the blood
glucose—lowering effect of insulin detemir with that of NPH insulin (NPH) ... Cited by 147 - Related articles - BL Direct - All 7 versions
[CITATION] Benefits of insulin detemir over NPH insulin in children and adolescents with type 1 …
GA Brunner, G Sendlhofer, A Wutte, M … - Experimental and clinical endocrinology & diabetes, 2000 - thieme-connect.com NN304 is a long-acting insulin analogue that is acylated with a 14-C-fatty acid
chain. Protraction of action of this novel insulin analogue is due not to slow
absorption after subcutaneous administration but to reversible binding to ... Cited by 62 - Related articles - BL Direct - All 6 versions
- ►fmmu.edu.cn [PDF] - Free from Publisher P Home, P Bartley, D Russell-Jones, H … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—With both insulin detemir groups, clinic fasting plasma glucose was
lower than with NPH insulin (IDet 12h vs. NPH, −1.5 mmol/l [95% CI −2.51 to
−0.48], P = 0.004; IDet morn+bed vs. NPH, −2.3 mmol/l (−3.32 to ... Cited by 152 - Related articles - BL Direct - All 7 versions
[CITATION] Pharmacokinetics of insulin detemir in subjects with renal or hepatic impairment
HB Mortensen, A Lindholm, BS Olsen, B … - European journal of pediatrics, 2000 - Springer Abstract The pharmacokinetics of the novel, rapid-acting insulin aspart were
compared with those of soluble human insulin following subcutaneous
administration in nine children (aged 6±12 years) and nine adolescents ... Cited by 68 - Related articles - BL Direct - All 4 versions
